New 4-Week allergy shot could ease fall hay fever
NCT ID NCT07563439
First seen May 06, 2026 · Last updated May 06, 2026
Summary
This study tests a new allergy shot called PollenVax for people with moderate-to-severe hay fever caused by mugwort pollen. The shot is given as 4 weekly injections and aims to reduce symptoms like sneezing, runny nose, and itchy eyes. About 138 adults aged 18-65 will take part, and half will receive the real shot while the others get a placebo. The study will measure how well the treatment works during peak pollen season and check for any side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHINITIS, ALLERGIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Limited Liability Partnership "Medcenter-Rakhat"
Almaty, Almaty, 050010, Kazakhstan
Contact
Contact
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Conditions
Explore the condition pages connected to this study.